Hippuric acid: Could became a barometer for frailty and geriatric syndromes?


Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
12 2021
Historique:
received: 26 05 2021
revised: 07 09 2021
accepted: 17 09 2021
pubmed: 25 9 2021
medline: 29 1 2022
entrez: 24 9 2021
Statut: ppublish

Résumé

Aging is a natural biological event that has some downsides such as increased frailty, decline in cognitive and physical functions leading to chronical diseases, and lower quality of life. There is therefore a pressing need of reliable biomarkers to identify populations at risk of developing age-associated syndromes in order to improve their quality of life, promote healthy ageing and a more appropriate clinical management, when needed. Here we discuss the importance of hippuric acid, an endogenous co-metabolite, as a possible hallmark of human aging and age-related diseases, summarizing the scientific literature over the last years. Hippuric acid, the glycine conjugate of benzoic acid, derives from the catabolism by means of intestinal microflora of dietary polyphenols found in plant-based foods (e.g. fruits, vegetables, tea and coffee). In healthy conditions hippuric acid levels in blood and/or urine rise significantly during aging while its excretion drops in conditions related with aging, including cognitive impairments, rheumatic diseases, sarcopenia and hypomobility. This literature highlights the utility of hippuric acid in urine and plasma as a plausible hallmark of frailty, related to low fruit and vegetable intake and changes in gut microflora.

Identifiants

pubmed: 34560280
pii: S1568-1637(21)00213-0
doi: 10.1016/j.arr.2021.101466
pii:
doi:

Substances chimiques

Hippurates 0
hippuric acid TE0865N2ET

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101466

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Giulia De Simone (G)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Claudia Balducci (C)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Gianluigi Forloni (G)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Roberta Pastorelli (R)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Laura Brunelli (L)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: laura.brunelli@marionegri.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH